Testing a new cell therapy for Sjogren's syndrome
Treatments studied
Part of Bones, joints & muscles, Eyes & vision, Immune system & allergy, Mouth & dental, Skin clinical trials.
This study tests an experimental treatment made from a person's own blood cells, called HuMoSCs, to see if it can help reduce dryness and other symptoms of Sjogren's syndrome. It is for people who have symptoms of the condition but have not yet been officially diagnosed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have symptoms that might be Sjogren's syndrome and are scheduled for tests to find out.
- You are willing to give verbal consent to take part.
- You are not currently pregnant, breastfeeding, or in labor.
- You are not under legal guardianship or any court-ordered protection.
- You are an adult (18 years or older) and able to make your own decisions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who may have Sjögren’s disease to better understand how to diagnose it. If you have symptoms like dry eyes or dry mouth, this could help researchers confirm the diagnosis and learn what tests best explain it.
This study looks at diseases that involve the salivary (saliva) glands, and may also include people with active hepatitis, oral cancer, or healthy adults. Researchers collect blood, urine, saliva, and sometimes tissue to better understand what’s happening and how these conditions relate to saliva and oral health.
This study compares saliva, dental plaque, and stool samples from people with Sjogren's syndrome and healthy controls to understand how the mouth and gut bacteria differ. Participation is simple and involves providing samples during a dental visit and at home.
This study follows people with Sjogren’s disease to understand how it develops and how symptoms naturally change over time. The goal is to improve understanding and future care rather than provide a new immediate treatment.
This study looks at an immune reaction (called anti-Ro/SSA IgE) to see how active primary Sjögren’s disease is. It may help doctors better understand what’s driving symptoms and activity levels over time.
This trial tests a new treatment using stem cells and exosomes (tiny healing particles) injected into the salivary glands under the jaw. It aims to improve saliva production and relieve dry mouth in people with primary Sjögren syndrome.
Hear when a new Sjogren's Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.